Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma

Journal of Surgical Oncology

Volumn 105, Issue 8, 2012, Pages 830-834

  Shen, Aidong ^a   Zhang, Yunqing ^a   Yang, Huiguang ^a   Xu, Ruisheng ^a   Huang, Guowei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

osteosarcoma; RNA interference; ZEB1

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC FINGER E BOX BINDING PROTEIN 1; ZINC FINGER PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BONE TISSUE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; ADULT; BLOTTING, WESTERN; BONE AND BONES; BONE NEOPLASMS; CELLS, CULTURED; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84861099981     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23012     Document Type: Article

References (39)

1. Zwaga T, Bovee JV, Kroon HM,: Osteosarcoma of the femur with skip, lymph node, and lung metastases. Radiographics 2008; 28: 277-283.
2. Mankin HJ, Hornicek FJ, Rosenberg AE, et al.: Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 2004; 429: 286-291. (Pubitemid 39579224)
3. Dorfman HD, Czerniak B,: Bone cancers. Cancer 1995; 75: 203-210.
4. Ferguson WS, Goorin AM,: Current treatment of osteosarcoma. Cancer Invest 2001; 19: 292-315. (Pubitemid 32374371)
5. Wittig JC, Bickels J, Priebat D, et al.: Osteosarcoma: A multidisciplinary approach to diagnosis and treatment. Am Fam Physician 2002; 65: 1123-1132.
6. Bacci G, Lari S,: Current treatment of high grade osteosarcoma of the extremity: Review. J Chemother 2001; 13: 235-243. (Pubitemid 32575134)
7. Tumbar T, Guasch G, Greco V, et al.: Defining the epithelial stem cell niche in skin. Science 2004; 303: 359-363. (Pubitemid 38095773)
8. Spradling A, Drummond-Barbosa D, Kai T,: Stem cells find their niche. Nature 2001; 414: 98-104. (Pubitemid 33041633)
9. Funahashi J, Sekido R, Murai K, et al.: Delta-crystallin enhancer binding protein delta EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. Development 1993; 119: 433-446. (Pubitemid 23293186)
10. Stridh P, Thessen Hedreul M, Beyeen AD, et al.: Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat. PLoS ONE 2010; 5: e12716.
11. Xiao DK, He JX,: Epithelial mesenchymal transition lung cancer. J Thorac Dis 2010; 2: 154-159.
12. Vandewalle C, Comijn J, De Craene B, et al.: SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 2005; 33: 6566-6578. (Pubitemid 41806421)
13. Pan J, Yang M,: The role of epithelial-mesenchymal transition in pancreatic cancer. J Gastrointest Oncol 2011; 2: 151-156.
14. Hidaka T, Nakahata S, Hatakeyama K, et al.: Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood 2008; 112: 383-393.
15. Postigo AA, Dean DC,: Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol Cell Biol 1999; 19: 7961-7971. (Pubitemid 30413991)
16. Williams TM, Moolten D, Burlein J, et al.: Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 1991; 254: 1791-1794. (Pubitemid 21917528)
17. Genetta T, Ruezinsky D, Kadesch T,: Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: Implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol 1994; 14: 6153-6163.
18. Fontemaggi G, Gurtner A, Strano S, et al.: The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol 2001; 21: 8461-8470. (Pubitemid 33108605)
19. Putzke AP, Ventura AP, Bailey AM, et al.: Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. Am J Pathol 2011; 179: 400-410.
20. Argast GM, Krueger JS, Thomson S, et al.: Inducible expression of TGFbeta, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model. Clin Exp Metastasis 2011; 28: 593-614.
21. Lorenzatti G, Huang W, Pal A, et al.: CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 2011; 124: 1752-1758.
22. Bao B, Wang Z, Ali S, et al.: Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011; 307: 26-36.
23. Roy BC, Kohno T, Iwakawa R, et al.: Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer 2010; 70: 136-145.
24. Kim T, Veronese A, Pichiorri F, et al.: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011; 208: 875-883.
25. Enneking WF, Spanier SS, Goodman MA,: A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res 2003; 415: 4-18.
26. Muller A, Homey B, Soto H, et al.: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56. (Pubitemid 32225831)
27. Poullet P, Gautreau A, Kadare G, et al.: Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion. J Biol Chem 2001; 276: 37686-37691.
28. Bateman G, Ricketts DN, Saunders WP,: Fibre-based post systems: A review. Br Dent J 2003; 195: 43-48; discussion 37. (Pubitemid 38843644)
29. Yu HG, Li JY, Yang YN, et al.: Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett 2003; 195: 43-51.
30. Qian Y, Corum L, Meng Q, et al.: PI3K induced actin filament remodeling through Akt and p70S6K1: Implication of essential role in cell migration. Am J Physiol Cell Physiol 2004; 286: C153-C163. (Pubitemid 38055824)
31. Eger A, Aigner K, Sonderegger S, et al.: DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375-2385. (Pubitemid 40546696)
32. van Roy F, Berx G,: The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756-3788.
33. Rachagani S, Senapati S, Chakraborty S, et al.: Activated Kras(G12D) is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. Br J Cancer 2011; 104: 1038-1048.
34. Erdem H, Gundogdu C, Sipal S,: Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma. Exp Mol Pathol 2011; 90: 312-317.
35. Saad AA, Awed NM, Abd Elkerim NN, et al.: Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol 2010; 17: 3059-3067.
36. Guo BH, Feng Y, Zhang R, et al.: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 2011; 10: 10.
37. Rajeshwari KV, Lata K, Pant DC, et al.: A novel process using enhanced acidification and a UASB reactor for biomethanation of vegetable market waste. Waste Manag Res 2001; 19: 292-300. (Pubitemid 33014822)
38. Fletcher L,: New Zealand debacle GMO undermines green lobby. Nat Biotechnol 2001; 19: 292.
39. Frost HM,: Cybernetic aspects of bone modeling and remodeling, with special reference to osteoporosis and whole-bone strength. Am J Hum Biol 2001; 13: 235-248. (Pubitemid 32229559)